Abstract
Aim: to provide the key trends in the use of a modern combined medicinal product of ciprofloxacin and ornidazole. Key points. The product has a combined antimicrobial and antiprotozoal effect; its pharmacological action is a result of the properties of the active ingredients — ciprofloxacin and ornidazole. The article describes the efficacy of this combination against gynaecological infections. Conclusion. The use of the ciprofloxacin and ornidazole combination demonstrates therapeutic effect against a majority of urinogenital gynaecological conditions. The product is beneficial in case of concurrent infections, various vaginitis, pelvic inflammations and for prevention of post-surgery complications. Keywords: ornidazole, ciprofloxacin, combination, infections, concurrent infections, pelvic inflammations, sexually transmitted infections.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
